|
DDX52 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.44249065417534E-15 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.44089209850063E-15 |
| Normal-vs-Stage2 |
3.543800E-03 |
| Normal-vs-Stage3 |
4.51970016968062E-10 |
| Normal-vs-Stage4 |
7.93319999999875E-05 |
| Stage1-vs-Stage2 |
2.965900E-02 |
| Stage1-vs-Stage3 |
8.992400E-01 |
| Stage1-vs-Stage4 |
2.716800E-01 |
| Stage2-vs-Stage3 |
4.827800E-02 |
| Stage2-vs-Stage4 |
3.379400E-01 |
| Stage3-vs-Stage4 |
3.459000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.848000E-04 |
| Normal-vs-Asian |
4.42969999999709E-05 |
| Caucasian-vs-AfricanAmerican |
6.608600E-01 |
| Caucasian-vs-Asian |
5.311600E-01 |
| AfricanAmerican-vs-Asian |
4.619200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.0949999795784E-09 |
| Normal-vs-Female |
5.99520433297585E-15 |
| Male-vs-Female |
6.621000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6565637750432E-12 |
| Normal-vs-Age(41-60Yrs) |
1.59899871121638E-11 |
| Normal-vs-Age(61-80Yrs) |
1.76600000001415E-06 |
| Normal-vs-Age(81-100Yrs) |
2.504900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.488650E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.030400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.589620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.412000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.699200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.941400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.687600E-01 |
| Classical-VS-Follicular |
1.62458935193399E-12 |
| Classical-VS-Other |
1.535760E-01 |
| Classical-VS-Normal |
1.11022302462516E-16 |
| Tall-VS-Follicular |
2.8679999486414E-09 |
| Tall-VS-Other |
8.829900E-02 |
| Tall-VS-Normal |
6.46729999553841E-08 |
| Follicular-VS-Other |
1.482970E-01 |
| Follicular-VS-Normal |
8.171800E-01 |
| Other-VS-Normal |
2.009200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.05990000109912E-08 |
| Normal-vs-N1 |
2.27680000000063E-05 |
| N0-vs-N1 |
3.632600E-01 |
|
|
